论文部分内容阅读
难治性非何杰金淋巴瘤的巩固疗法须永真司根据治疗的反应及自然病程，非何杰金淋巴瘤（ＮＨＬ）分为中、高度恶性组和低度恶性组。其中，已明确的是中、高度恶性组的ＮＨＬ，通过相应的治疗有治愈的可能。这些化疗，从ＣＨＯＰ疗法过渡到第二、第三代治疗，其治愈的可能性...
Treatment of refractory non-Hodgkin’s lymphoma According to the response to treatment and the natural history, non-Hodgkin’s lymphoma (NHL) is divided into moderately, highly malignant and lowly malignant groups. Among them, it is clear that the NHL in the middle and high malignant group is cured by the corresponding treatment. These chemotherapy, the transition from CHOP therapy to the second and third generation of treatment, the possibility of its cure ...